REVVITY, INC Cost of Revenue
REVVITY, INC (RVTY) reported Cost of Revenue of $312.82 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- REVVITY, INC cost of goods and services sold for the quarter ending 2026-07-05 was $312.82M, a 4.55% decline year-over-year.
- REVVITY, INC cost of goods and services sold for the quarter ending 2026-04-05 was $323.46M, a 11.84% increase year-over-year.
- REVVITY, INC cost of goods and services sold for the quarter ending 2025-09-28 was $324.35M, a 8.39% increase year-over-year.
- REVVITY, INC cost of goods and services sold for the quarter ending 2025-06-29 was $327.73M, a 7.04% increase year-over-year.
- REVVITY, INC cost of goods and services sold for fiscal 2018 was $1.44B.
- REVVITY, INC cost of goods and services sold for fiscal 2011 was $945.72M, a 11.03% increase from fiscal 2010.
- REVVITY, INC cost of goods and services sold for fiscal 2010 was $851.78M, a 8.01% decline from fiscal 2008.
- REVVITY, INC cost of goods and services sold for fiscal 2008 was $925.97M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|---|
| 2026-07-05 | $312.82M 10-Q · filed 2026-08-11 | $636.28M 10-Q · filed 2026-08-11 | |||||
| 2026-04-05 | $323.46M 10-Q · filed 2026-05-12 | ||||||
| 2025-09-28 | $324.35M 10-Q · filed 2025-11-04 | $652.07M derived: sum of 2 quarters · filed 2026-08-11 | $941.29M 10-Q · filed 2025-11-04 | ||||
| 2025-06-29 | $327.73M 10-Q · filed 2026-08-11 | $616.94M 10-Q · filed 2026-08-11 | |||||
| 2025-03-30 | $289.22M 10-Q · filed 2026-05-12 | ||||||
| 2024-09-29 | $299.23M 10-Q · filed 2025-11-04 | $605.41M derived: sum of 2 quarters · filed 2025-11-04 | $900.28M 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | $306.18M 10-Q · filed 2025-08-05 | $601.05M 10-Q · filed 2025-08-05 | |||||
| 2024-03-31 | $294.87M 10-Q · filed 2025-05-06 | ||||||
| 2023-10-01 | $298.22M 10-Q · filed 2024-11-06 | $604.96M derived: sum of 2 quarters · filed 2024-11-06 | $898.46M 10-Q · filed 2024-11-06 | ||||
| 2023-07-02 | $306.74M 10-Q · filed 2024-08-06 | $600.23M 10-Q · filed 2024-08-06 | |||||
| 2023-04-02 | $293.50M 10-Q · filed 2024-05-07 | ||||||
| 2022-10-02 | $304.76M 10-Q · filed 2023-11-07 | $648.68M derived: sum of 2 quarters · filed 2023-11-07 | $1.02B 10-Q · filed 2023-11-07 | ||||
| 2022-07-03 | $343.93M 10-Q · filed 2023-08-09 | $563.41M 10-Q · filed 2022-08-09 | $712.35M 10-Q · filed 2023-08-09 | $1.14B 10-Q · filed 2022-08-09 | |||
| 2022-04-03 | $368.42M 10-Q · filed 2023-05-12 | $580.21M 10-Q · filed 2022-05-10 | |||||
| 2021-10-03 | $338.45M 10-Q · filed 2022-11-14 | $534.85M 10-Q · filed 2021-11-09 | $881.73M derived: sum of 2 quarters · filed 2022-11-14 | $1.01B 10-Q · filed 2022-11-14 | $1.60B 10-Q · filed 2021-11-09 | ||
| 2021-07-04 | $543.28M 10-Q · filed 2022-08-09 | $1.07B 10-Q · filed 2022-08-09 | |||||
| 2021-04-04 | $522.54M 10-Q · filed 2022-05-10 | ||||||
| 2020-10-04 | $436.58M 10-Q · filed 2021-11-09 | $800.95M derived: sum of 2 quarters · filed 2021-11-09 | $1.15B 10-Q · filed 2021-11-09 | ||||
| 2020-07-05 | $364.37M 10-Q · filed 2021-08-10 | $708.75M 10-Q · filed 2021-08-10 | |||||
| 2020-04-05 | $344.37M 10-Q · filed 2021-05-11 | ||||||
| 2019-09-29 | $364.65M 10-Q · filed 2020-11-10 | $739.37M derived: sum of 2 quarters · filed 2020-11-10 | $1.08B 10-Q · filed 2020-11-10 | $1.46B derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $374.72M 10-Q · filed 2020-08-11 | $715.65M 10-Q · filed 2020-08-11 | $1.10B derived: sum of 3 quarters · filed 2020-08-11 | $1.44B derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | $340.93M 10-Q · filed 2020-05-12 | $721.03M derived: sum of 2 quarters · filed 2020-05-12 | $1.06B derived: sum of 3 quarters · filed 2020-05-12 | $1.43B derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-30 | $380.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $722.09M derived: sum of 2 quarters · filed 2019-11-05 | $1.09B derived: sum of 3 quarters · filed 2019-11-05 | $1.44B 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $341.99M 10-Q · filed 2019-11-05 | $705.21M derived: sum of 2 quarters · filed 2019-11-05 | $1.06B 10-Q · filed 2019-11-05 | ||||
| 2018-07-01 | $363.22M 10-Q · filed 2019-08-06 | $714.97M 10-Q · filed 2019-08-06 | |||||
| 2018-04-01 | $351.75M 10-Q · filed 2019-05-07 | ||||||
| 2017-10-01 | $285.45M 10-Q · filed 2017-11-07 | $574.91M derived: sum of 2 quarters · filed 2017-11-07 | $849.42M 10-Q · filed 2017-11-07 | ||||
| 2017-07-02 | $289.46M 10-Q · filed 2017-08-08 | $563.96M 10-Q · filed 2017-08-08 | |||||
| 2017-04-02 | $274.36M 10-Q · filed 2018-05-08 | $274.50M 10-Q · filed 2017-05-09 | |||||
| 2016-10-02 | $265.94M 10-Q · filed 2017-11-07 | $287.25M 10-Q · filed 2016-11-08 | $548.63M derived: sum of 2 quarters · filed 2017-11-07 | $811.56M 10-Q · filed 2017-11-07 | $883.23M 10-Q · filed 2016-11-08 | ||
| 2016-07-03 | $282.69M 10-Q · filed 2017-08-08 | $307.38M 10-Q · filed 2016-08-09 | $545.62M 10-Q · filed 2017-08-08 | $595.97M 10-Q · filed 2016-08-09 | |||
| 2016-04-03 | $262.93M 10-Q · filed 2017-05-09 | $288.59M 10-Q · filed 2016-05-10 | |||||
| 2015-10-04 | $308.83M 10-Q · filed 2016-11-08 | $620.23M derived: sum of 2 quarters · filed 2016-11-08 | $911.75M 10-Q · filed 2016-11-08 | ||||
| 2015-06-28 | $311.39M 10-Q · filed 2016-08-09 | $602.92M 10-Q · filed 2016-08-09 | |||||
| 2015-03-29 | $291.53M 10-Q · filed 2016-05-10 | ||||||
| 2014-09-28 | $298.74M 10-Q · filed 2015-11-10 | $606.93M derived: sum of 2 quarters · filed 2015-11-10 | $901.82M 10-Q · filed 2015-11-10 | ||||
| 2014-06-29 | $308.19M 10-Q · filed 2015-08-04 | $603.08M 10-Q · filed 2015-08-04 | |||||
| 2014-03-30 | $294.90M 10-Q · filed 2015-05-05 | $296.38M 10-Q · filed 2014-05-06 | |||||
| 2013-09-29 | $288.83M 10-Q · filed 2014-11-04 | $290.76M 10-Q · filed 2013-11-05 | $587.84M derived: sum of 2 quarters · filed 2014-11-04 | $866.34M 10-Q · filed 2014-11-04 | $872.26M 10-Q · filed 2013-11-05 | ||
| 2013-06-30 | $299.01M 10-Q · filed 2014-08-05 | $301.00M 10-Q · filed 2013-08-06 | $577.51M 10-Q · filed 2014-08-05 | $581.49M 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | $280.49M 10-Q · filed 2014-05-06 | ||||||
| 2012-09-30 | $278.86M 10-Q · filed 2013-11-05 | $561.86M derived: sum of 2 quarters · filed 2013-11-05 | $840.74M 10-Q · filed 2013-11-05 | ||||
| 2012-07-01 | $283.00M 10-Q · filed 2013-08-06 | $561.87M 10-Q · filed 2013-08-06 | |||||
| 2012-04-01 | $278.88M 10-Q · filed 2013-05-06 | ||||||
| 2011-10-02 | $253.58M 10-Q · filed 2012-11-06 | $254.19M 10-Q · filed 2011-11-04 | $523.45M derived: sum of 2 quarters · filed 2012-11-06 | $770.32M 10-Q · filed 2012-11-06 | $772.32M 10-Q · filed 2011-11-04 | $1.03B derived: sum of 4 quarters · filed 2012-11-06 | |
| 2011-07-03 | $269.87M 10-Q · filed 2012-08-07 | $270.49M 10-Q · filed 2011-08-10 | $516.74M 10-Q · filed 2012-08-07 | $518.13M 10-Q · filed 2011-08-10 | $778.38M derived: sum of 3 quarters · filed 2012-08-07 | $1.01B derived: sum of 4 quarters · filed 2012-08-07 | |
| 2011-04-03 | $246.87M 10-Q · filed 2012-05-08 | $247.64M 10-Q · filed 2011-05-10 | $508.51M derived: sum of 2 quarters · filed 2012-05-08 | $741.87M derived: sum of 3 quarters · filed 2012-05-08 | $974.23M derived: sum of 4 quarters · filed 2012-05-08 | ||
| 2011-01-02 | $261.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $495.00M derived: sum of 2 quarters · filed 2011-11-04 | $727.36M derived: sum of 3 quarters · filed 2011-11-04 | $945.72M 10-K · filed 2011-03-01 | |||
| 2010-10-03 | $233.36M 10-Q · filed 2011-11-04 | $465.72M derived: sum of 2 quarters · filed 2011-11-04 | $684.07M 10-Q · filed 2011-11-04 | $918.71M derived: sum of 4 quarters · filed 2011-11-04 | |||
| 2010-07-04 | $232.36M 10-Q · filed 2011-08-10 | $285.04M 10-Q · filed 2010-08-10 | $450.71M 10-Q · filed 2011-08-10 | $551.50M 10-Q · filed 2010-08-10 | $685.35M derived: sum of 3 quarters · filed 2011-08-10 | $893.63M derived: sum of 4 quarters · filed 2011-08-10 | |
| 2010-04-04 | $218.35M 10-Q · filed 2011-05-10 | $452.99M derived: sum of 2 quarters · filed 2011-05-10 | $661.27M derived: sum of 3 quarters · filed 2011-05-10 | $911.47M derived: sum of 4 quarters · filed 2011-05-10 | |||
| 2010-01-03 | $234.63M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $442.91M derived: sum of 2 quarters · filed 2011-03-01 | $693.11M derived: sum of 3 quarters · filed 2011-03-01 | $851.78M 10-K · filed 2011-03-01 | |||
| 2009-10-04 | $208.28M 10-Q · filed 2010-11-10 | $458.48M derived: sum of 2 quarters · filed 2010-11-10 | $617.15M 10-Q · filed 2010-11-10 | ||||
| 2009-07-05 | $250.20M 10-Q · filed 2010-08-10 | $496.82M 10-Q · filed 2010-08-10 | |||||
| 2008-12-28 | $925.97M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |